Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
Secura Bio, Inc. ( an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology medicines, today announced that Chip Romp, Chief Executive ...
Various tissues and organs in the human body, such as nerves, heart, bones, and skin, rely on bioelectrical signals to maintain function and support ...
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today provided a corporate update, including an update on the encouraging enrollment ...
Anthocyanin-rich purple foods contain plant pigments that influence antioxidant and inflammatory pathways and are linked in ...
Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.
Atomic defects in nanodiamonds enable both precise heating of lysosomes inside macrophages and nanoscale temperature ...
Preclinical data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα, strongly inhibits pAKT signaling in tumor ...
Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of ...
Ovarian cancer is among the most lethal gynecological cancers because it is often detected at an advanced stage and can be ...
Tesamorelin is a synthetic 44–amino acid analog of growth hormone–releasing hormone (GHRH) that has attracted attention outside the experimental domain for its potential as a research tool. This ...
In the future, medicines made from cannabis could help fight ovarian cancer. A research team studying two natural chemicals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results